or Try an Advanced Search...

    Skin Inflammation Stocks List

    Symbol Grade Name % Change
    CNTB C Connect Biopharma Holdings Limited -2.96
    ARGX D argenx SE -0.31
    KRYS D Krystal Biotech, Inc. -0.10
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Inflammation Biopharmaceutical Immunotherapy Acute Myeloid Leukemia Animal Physiology Asthma Atopic Dermatitis Autoimmune Disease Biology Cancer Cancer Immunotherapy Chronic Rhinosinusitis Clinical Development Clinical Medicine Dehydration Dermatological Diseases Dyslipidemia Epidermolysis Bullosa Gene Therapy Genetic Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Skin Inflammation stocks.

    Symbol Grade Name Weight
    EWK A iShares MSCI Belgium Capped Investable Market Index Fund 6.71
    IBRN D iShares Neuroscience and Healthcare ETF 4.58
    BBH C Market Vectors Biotech ETF 4.57
    HELX D Franklin Genomic Advancements ETF 4.04
    MNTL D Tema Neuroscience and Mental Health ETF 3.57
    View all Skin Inflammation ETFs...
    Compare ETFs
    Compare BBH to HELX Compare BBH to MNTL Compare IBRN to BBH

        Skin Inflammation Stocks Recent News

        Date Stock Title
        May 7 ARGX argenx announces results of Annual General Meeting of Shareholders
        May 7 KRYS Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript
        May 7 CNTB Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
        May 7 ARGX argenx: Innovation Over Losses In Autoimmune Arena
        May 7 KRYS Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
        May 7 ARGX argenx to Present at BofA Securities 2024 Health Care Conference
        May 7 KRYS Q1 2024 Krystal Biotech Inc Earnings Call
        May 6 KRYS Krystal Biotech, Inc. (KRYS) Q1 2024 Earnings Call Transcript
        May 6 KRYS Krystal Biotech Inc (KRYS) Surpasses Revenue Estimates in Q1 2024
        May 6 KRYS Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates
        May 6 KRYS Krystal Biotech misses top-line and bottom-line estimates; reaffirms FY24 outlook
        May 6 KRYS Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates
        May 3 KRYS Krystal Biotech Q1 2024 Earnings Preview
        May 3 KRYS Why Krystal Biotech (KRYS) Might Surprise This Earnings Season
        May 2 CNTB Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
        May 2 KRYS Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
        May 2 ARGX argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
        Related Industries: Biotechnology
        Related Stock Lists: Inflammation Biopharmaceutical Immunotherapy Acute Myeloid Leukemia Animal Physiology Asthma Atopic Dermatitis Autoimmune Disease Biology Cancer Cancer Immunotherapy Chronic Rhinosinusitis Clinical Development Clinical Medicine Dehydration Dermatological Diseases Dyslipidemia Epidermolysis Bullosa Gene Therapy Genetic Diseases
        Skin Inflammation

        Skin inflammation is a condition in which the skin becomes red, swollen, and itchy. It can be caused by a variety of factors, including allergies, irritants, infections, and autoimmune disorders. Treatment for skin inflammation depends on the underlying cause, but may include topical medications, oral medications, or light therapy.

        Browse All Tags